Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-13

Clinical Trial Update: Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated reduction of night-time blood pressure in pediatric kidney transplant recipients and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwell Health | Conditions: Hypertension Secondary to Kidney Transplant | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-04-13